Gilead Sciences reports positive drug results for remdesivir as coronavirus treatment

Gilead Sciences reports positive drug results for remdesivir as coronavirus treatment

Pharmaceutical company Gilead Sciences on Wednesday reported potentially encouraging results from a trial for a drug that's being tested as a treatment for the coronavirus.

Gilead said that the antiviral drug remdesivir produced "similar improvement" in patients over a 10-day treatment plan compared with a five-day treatment plan – and that it recorded "no new safety" issues among hospitalized patients who "well-tolerated" the treatment in the study.

“The study demonstrates the potential for some patients to be treated with a 5-day regimen, which could significantly expand the number of patients who could be treated with our current supply of remdesivir," said Merdad Parsey, chief medical officer of Gilead Sciences, in a statement. "This is particularly important in the setting of a pandemic, to help hospitals and healthcare workers treat more patients in urgent need of care."

Gilead's stock rose 9% in premarket trading.

The initial results released Wednesday come after a report two weeks ago by the medical site STAT suggested potentially positive results in one of its remdesivir trials.

What is remdesivir?:Gilead Sciences drug reportedly shows promise treating coronavirus

In this March 2020 photo provided by Gilead Sciences, rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States.

Remdesivir is one of numerous drugs under development to treat or prevent the coronavirus. Clinical trials are conducted to ensure safety and efficacy, and there's no guarantee Gilead's initial results will lead to a commercially available treatment. But medical professionals have had high hopes for remdesivir since the coronavirus pandemic began.

Gilead emphasized that remdesivir "is not yet licensed or approved anywhere globally and has not yet been demonstrated to be safe or effective for the treatment of COVID-19."

This particular study involved patients suffering from pneumonia and reduced oxygen levels who did not require ventilation when the study began.

Gilead reported that it took 10 days for 50% of the patients in the five-day treatment group to show clinical improvement, compared with 11 days for patients in the 10-day treatment group.

More than half of patients in both groups were discharged from the hospital after two weeks.

Follow USA TODAY reporter Nathan Bomey on Twitter @NathanBomey.

Source: https://www.usatoday.com/story/money/2020/04/29/gilead-sciences-coronavirus-drug-remdesivir-covid-19/3046608001/

News Related

ORTHER NEWS

Trump’s ‘mission accomplished’ moment is premature and deadly. We have not defeated COVID.

Desperate for crowds and adoration, Trump has put his most fervent supporters at risk of getting a deadly disease. Future historians will be astonished. Read more »

NFLPA president JC Tretter says NFL is putting season, players at risk with its coronavirus approach

NFL Players Association president JC Tretter said Tuesday the NFL is putting the 2020 season at risk with its coronavirus approach, calling on the league to better “prioritize player safety.” “Like many other... Read more »

Brazilian President Jair Bolsonaro says he tested positive for the coronavirus

RIO DE JANEIRO (AP) — Brazil’s President Jair Bolsonaro says he has tested positive for COVID-19 after months of downplaying the virus’ severity. Bolsonaro confirmed the test results while wearing a mask and... Read more »

Venice Film Festival forges ahead amid COVID-19 pandemic with reduced lineup

The show will go on for the Venice Film Festival in September, but with a few modifications due to the COVID-19 pandemic. Organizers said Tuesday that they are pushing forward with plans for... Read more »

Amtrak offers buy-one, get-one promotion on its sleeper trains amid COVID-19 — with a catch

Amtrak wants you to have sweet dreams the next time you travel — so much so that it’s sweetening the deal on its sleeper “roomettes.” The rail service is offering a buy-one-get-one-free discount... Read more »

Florida teen treated with hydroxychloroquine at home before dying of COVID-19, report says

FORT MEYERS, Fla. – The family of a 17-year-old Florida girl who died last month from COVID-19 treated her symptoms at home for nearly a week before taking her to a hospital, a... Read more »

Mookie Betts worried MLB coronavirus testing woes could prevent him from ever playing for Dodgers

During nearly four months away from the game, Mookie Betts said he “stayed away from baseball to keep myself sane.” It’s not hard to understand why. The 2018 American League Most Valuable Player... Read more »

Tom Hanks doesn’t get ‘how common sense has somehow been put into question’ with coronavirus

Read more »

Can Gov. DeSantis force Florida schools to reopen amid the coronavirus pandemic? Some school leaders seem doubtful.

PALM BEACH, Fla. — As concern about the state order spread online, some school leaders said: Not so fast. As Florida educators puzzle over how to start the new academic year, Gov. Ron... Read more »

Texas surpasses 200,000 coronavirus cases after 4th of July holiday weekend

AUSTIN, Texas – Texas reached 200,000 total COVID-19 cases Monday, just 17 days after crossing the 100,000 threshold, a figure that took the state nearly four months to hit. The grim milestone came... Read more »